<DOC>
	<DOC>NCT01387594</DOC>
	<brief_summary>Study is designed to show a lack of effect on white blood cells circulating in the spinal fluid.</brief_summary>
	<brief_title>Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Enteritis</mesh_term>
	<mesh_term>Ileitis</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>males and females &gt;=18 and =&lt;75 years For CD subjects: hsCRP &gt; 5 mg/L and HarveyBradshaw Index &gt; 8 OR when HBI cannot be determined (ie if stoma is present) or hsCRP &lt; 5mg/L then: active lesions on colonoscopy or flexible sigmoidoscopy or active Crohn's disease on CT or MR enterography For UC subjects: diagnosis of UC &gt; 3 months; must have endoscopy to confirm active disease during screening; total mayo score of 6 to 12 points and moderate to severe disease on endoscopy Pregnancy or breastfeeding TB or active enteric infections Entero vesicular fistulae Prior use of natalizumab or vedolizumab Right or left heart failure including symptomatic diastolic dysfunction or unexplained elevation of troponin I (&gt;0.05 ng/mL)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis</keyword>
</DOC>